Invention Grant
- Patent Title: Inhibitor compounds of phosphodiesterase type 10A
-
Application No.: US13534127Application Date: 2012-06-27
-
Publication No.: US09938269B2Publication Date: 2018-04-10
- Inventor: Hervé Geneste , Michael Ochse , Karla Drescher , Berthold Behl , Loic Laplanche , Jürgen Dinges , Clarissa Jakob , Katja Jantos
- Applicant: Hervé Geneste , Michael Ochse , Karla Drescher , Berthold Behl , Loic Laplanche , Jürgen Dinges , Clarissa Jakob , Katja Jantos
- Applicant Address: US IL North Chicago DE Wiesbaden
- Assignee: ABBVIE INC.,ABBVIE DEUTSCHLAND GMBH & CO KG
- Current Assignee: ABBVIE INC.,ABBVIE DEUTSCHLAND GMBH & CO KG
- Current Assignee Address: US IL North Chicago DE Wiesbaden
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D403/14 ; C07D405/14 ; C07D409/14 ; C07D413/14
Abstract:
The present invention relates to novel carboxamide compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating or controlling medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.
Public/Granted literature
- US20130005705A1 NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A Public/Granted day:2013-01-03
Information query
